Quantcast

Latest Gynecologic Oncology Group Stories

2010-03-08 10:00:00

Range of gynecologic oncology research is as impressive as pace CHICAGO, March 8 /PRNewswire-USNewswire/ -- In their continuing quest to eradicate women's cancer, gynecologic oncologists are developing new approaches to treatment, diagnosis and prevention of these diseases. An outstanding assortment of new research--covering everything from advances in chemotherapy (such as intraperitoneal therapy) and cancer screening, to surgical methods that improve quality of life and preventive...

2010-03-04 00:30:00

SEATTLE, March 4 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO(TM) used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in...

2010-02-10 09:00:00

CHICAGO, Feb. 10 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) will host its 41st ( )Annual Meeting on Women's Cancer March 14-17, 2010 at the Moscone West Convention Center in San Francisco, California. This year's meeting will feature more than 434 scientific presentations in addition to lectures, workshops, symposia and postgraduate courses that focus on emerging science, clinical trials and treatment advances for physicians and health care professionals in the...

2010-02-10 07:20:55

Regimen with new drug triapine provides both significant reduction in cancer disease and cancer control Researchers at the Ireland Cancer Center of University Hospitals (UH) Case Medical Center, have published new findings that may lead to a new standard of care for patients with locally advanced cervical cancer. Published in the February issue of Clinical Cancer Research, the phase one study found that a new chemotherapy medicine, Triapine, was well tolerated in combination with...

2009-09-21 19:00:00

SEATTLE, Sept. 21 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced today that it will re-focus its resources on the approval of OPAXIO(TM) for its potential superiority indication in maintenance therapy for ovarian cancer. The Gynecologic Oncology Group (GOG) is conducting an ongoing phase III trial that evaluates the use of 12 months of OPAXIO therapy versus an untreated control arm. To date, 600 patients have been enrolled in this trial. CTI has...

2009-03-02 12:30:00

CHICAGO, March 2 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) and the American College of Obstetricians and Gynecologists (ACOG) have jointly developed a breast disease fellowship training program for gynecologic oncologists. Supported by a grant of $75,000 from ACOG, the program provides support for a gynecologic oncologist to complete a one-year fellowship training in the care and treatment of breast cancer and related disease. "As experts in women's...

2009-02-10 12:00:00

CHICAGO, Feb. 10 /PRNewswire-USNewswire/ -- David G. Mutch, MD, Director of the Division of Gynecologic Oncology and Ira and Judith Gall Professor of Obstetrics and Gynecology at the Washington University School of Medicine in St. Louis, Missouri, has been elected the 41st President of the Society of Gynecologic Oncologists (SGO) at the organization's 40th Annual Meeting, held February 5-8, 2009 in San Antonio, Texas. Dr. Mutch received a Bachelor of Arts degree from Carleton...

2009-01-29 10:40:00

How is this New Surgery Technique Impacting the Treatment of Women's Cancers? CHICAGO, Jan. 29 /PRNewswire-USNewswire/ -- Robotic-assisted surgery has become one of the fastest growing technological advances in the field of Gynecologic Oncology in the past few years. This minimally-invasive surgery (MIS) technique, its impact on the profession, and its role in the future of women's cancer care will be some of the topics discussed during the Society of Gynecologic Oncologists' (SGO) 2009...

2009-01-09 10:00:00

CHICAGO, Jan. 9 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) will host its 40th Annual Meeting on Women's Cancer, February 5-8, 2009 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. This year's meeting will feature more than 360 scientific presentations in addition to lectures, workshops, symposia, surgical labs and postgraduate courses that focus on emerging science, clinical trials and treatment advances for physicians and health care...

2008-12-22 13:47:00

CHICAGO, Dec. 22 /PRNewswire/ -- NEWS VALUE: More than 360 breaking research studies, along with 4 films, addressing the surgical, medical and radio therapeutic management, as well as the prevention of women's cancers will be presented at this preeminent educational and scientific event for physicians and healthcare professionals. WHAT: The Society of Gynecologic...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related